Psoriasis CKD ACEI/ARB/SGLT2I Supplemental Table 1

Name: Psoriasis CKD ACEI/ARB/SGLT2I Supplemental Table 1
Creator: Tarun Sontam
Published: 2025-03-18T15:29:43.011Z
Keywords: Angiotensin-Converting-Enzyme Inhibitor, Psoriasis, Chronic Kidney Disease, Database

Sontam, Tarun; Cho, Seo Won; Chen, Aaron; Chen, Helen; Raman, Justin; Tarbox, Michelle

doi:10.17632/wn68x9hrk3.1

Psoriasis CKD ACEI/ARB/SGLT2I Supplemental Table 1

Published: 18 March 2025| Version 1 | DOI: 10.17632/wn68x9hrk3.1

Contributors:

Tarun Sontam, Seo Won Cho, Aaron Chen, Helen Chen, Justin Raman, Michelle Tarbox

Description

Supplemental Table 1. Baseline characteristics of the psoriasis cohort and non-psoriasis (control) cohort before and after propensity score matching (PSM). Bold standard difference (std diff) indicates std diff > 0.1. A std diff < 0.1 was deemed satisfactory matching.

Psoriasis CKD ACEI/ARB/SGLT2I Supplemental Table 1

Description

Files

Categories

Licence